Waters Corporation $WAT Stock Position Raised by Fuller & Thaler Asset Management Inc.

Key Points

• Fuller & Thaler Asset Management Inc. increased its holdings in Waters Corporation by 28.3% in the first quarter, owning 59,607 shares valued at approximately $21.97 million.
• Waters Corporation reported quarterly earnings of $2.95 EPS, beating analysts' estimates and showing an 8.8% year-over-year revenue growth with total revenue of $771.33 million.
• Waters currently has a consensus rating of "Hold" among analysts, with an average price target of $378.73.

Fuller & Thaler Asset Management Inc. boosted its stake in Waters Corporation (NYSE:WAT - Free Report) by 28.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 59,607 shares of the medical instruments supplier's stock after buying an additional 13,146 shares during the period. Fuller & Thaler Asset Management Inc. owned 0.10% of Waters worth $21,969,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in WAT. Brighton Jones LLC increased its position in Waters by 112.9% in the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier's stock worth $471,000 after buying an additional 673 shares during the period. BI Asset Management Fondsmaeglerselskab A S boosted its stake in Waters by 38.1% during the fourth quarter. BI Asset Management Fondsmaeglerselskab A S now owns 2,926 shares of the medical instruments supplier's stock valued at $1,085,000 after buying an additional 807 shares in the last quarter. Norinchukin Bank The boosted its stake in Waters by 9.0% during the fourth quarter. Norinchukin Bank The now owns 2,648 shares of the medical instruments supplier's stock valued at $982,000 after buying an additional 219 shares in the last quarter. MetLife Investment Management LLC boosted its stake in Waters by 1.3% during the fourth quarter. MetLife Investment Management LLC now owns 17,292 shares of the medical instruments supplier's stock valued at $6,415,000 after buying an additional 228 shares in the last quarter. Finally, MML Investors Services LLC boosted its stake in Waters by 25.1% during the fourth quarter. MML Investors Services LLC now owns 12,886 shares of the medical instruments supplier's stock valued at $4,780,000 after buying an additional 2,589 shares in the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds.

Waters Stock Up 4.0%

Shares of WAT traded up $11.49 during midday trading on Friday, reaching $301.93. 500,262 shares of the stock were exchanged, compared to its average volume of 841,943. Waters Corporation has a 12-month low of $275.05 and a 12-month high of $423.56. The firm has a 50 day simple moving average of $314.26 and a 200-day simple moving average of $342.56. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55. The company has a market cap of $17.97 billion, a price-to-earnings ratio of 27.23, a P/E/G ratio of 2.71 and a beta of 1.04.

Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, topping analysts' consensus estimates of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The company had revenue of $771.33 million during the quarter, compared to the consensus estimate of $745.96 million. During the same period last year, the business earned $2.63 EPS. The business's quarterly revenue was up 8.8% on a year-over-year basis. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Research analysts forecast that Waters Corporation will post 12.86 EPS for the current year.

Analyst Ratings Changes

WAT has been the subject of several research reports. UBS Group reaffirmed a "neutral" rating on shares of Waters in a research note on Tuesday, July 15th. Wall Street Zen cut Waters from a "buy" rating to a "hold" rating in a research note on Saturday, July 26th. Bank of America raised their target price on Waters from $370.00 to $375.00 and gave the company a "neutral" rating in a research note on Thursday, June 26th. Wells Fargo & Company reduced their target price on Waters from $330.00 to $315.00 and set an "equal weight" rating for the company in a report on Tuesday, August 5th. Finally, Jefferies Financial Group set a $385.00 target price on Waters and gave the company a "buy" rating in a report on Monday, August 4th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, Waters has an average rating of "Hold" and a consensus price target of $378.73.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.